These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 37492477)

  • 1. Association between pH regulation of the tumor microenvironment and immunological state.
    Hosonuma M; Yoshimura K
    Front Oncol; 2023; 13():1175563. PubMed ID: 37492477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokines Orchestrating the Natural Killer-Myeloid Cell Crosstalk in the Tumor Microenvironment: Implications for Natural Killer Cell-Based Cancer Immunotherapy.
    Gaggero S; Witt K; Carlsten M; Mitra S
    Front Immunol; 2020; 11():621225. PubMed ID: 33584718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-Derived Lactate Creates a Favorable Niche for Tumor
    Jin M; Cao W; Chen B; Xiong M; Cao G
    Front Cell Dev Biol; 2022; 10():808859. PubMed ID: 35646923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanodrug regulates lactic acid metabolism to reprogram the immunosuppressive tumor microenvironment for enhanced cancer immunotherapy.
    Tian LR; Lin MZ; Zhong HH; Cai YJ; Li B; Xiao ZC; Shuai XT
    Biomater Sci; 2022 Jul; 10(14):3892-3900. PubMed ID: 35686599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory Components of the Thyroid Cancer Microenvironment: An Avenue for Identification of Novel Biomarkers.
    Jarboe T; Tuli NY; Chakraborty S; Maniyar RR; DeSouza N; Xiu-Min Li ; Moscatello A; Geliebter J; Tiwari RK
    Adv Exp Med Biol; 2021; 1350():1-31. PubMed ID: 34888842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of Cell-Cell Communication in Anaplastic Thyroid Cancer as an Immunotherapeutic Opportunity.
    Chakraborty S; Carnazza M; Jarboe T; DeSouza N; Li XM; Moscatello A; Geliebter J; Tiwari RK
    Adv Exp Med Biol; 2021; 1350():33-66. PubMed ID: 34888843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lactate from the tumor microenvironment - A key obstacle in NK cell-based immunotherapies.
    Jedlička M; Feglarová T; Janstová L; Hortová-Kohoutková M; Frič J
    Front Immunol; 2022; 13():932055. PubMed ID: 36330529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of the tumor microenvironment (TME) by melatonin.
    Mu Q; Najafi M
    Eur J Pharmacol; 2021 Sep; 907():174365. PubMed ID: 34302814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stromal cells (MSCs) and colorectal cancer: a troublesome twosome for the anti-tumour immune response?
    O'Malley G; Heijltjes M; Houston AM; Rani S; Ritter T; Egan LJ; Ryan AE
    Oncotarget; 2016 Sep; 7(37):60752-60774. PubMed ID: 27542276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactate in the Regulation of Tumor Microenvironment and Therapeutic Approaches.
    de la Cruz-López KG; Castro-Muñoz LJ; Reyes-Hernández DO; García-Carrancá A; Manzo-Merino J
    Front Oncol; 2019; 9():1143. PubMed ID: 31737570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment.
    Yang M; Li J; Gu P; Fan X
    Bioact Mater; 2021 Jul; 6(7):1973-1987. PubMed ID: 33426371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crosstalk between macrophages and natural killer cells in the tumor microenvironment.
    Zhou J; Zhang S; Guo C
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108374. PubMed ID: 34824036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor Microenvironment and Nitric Oxide: Concepts and Mechanisms.
    Vedenko A; Panara K; Goldstein G; Ramasamy R; Arora H
    Adv Exp Med Biol; 2020; 1277():143-158. PubMed ID: 33119871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor Microenvironment-Associated Extracellular Matrix Components Regulate NK Cell Function.
    Rossi GR; Trindade ES; Souza-Fonseca-Guimaraes F
    Front Immunol; 2020; 11():73. PubMed ID: 32063906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD8
    Farhood B; Najafi M; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8509-8521. PubMed ID: 30520029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual Relationship Between Stromal Cells and Immune Cells in the Tumor Microenvironment.
    Mun JY; Leem SH; Lee JH; Kim HS
    Front Immunol; 2022; 13():864739. PubMed ID: 35464435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The critical role of the tumor microenvironment in shaping natural killer cell-mediated anti-tumor immunity.
    Baginska J; Viry E; Paggetti J; Medves S; Berchem G; Moussay E; Janji B
    Front Immunol; 2013 Dec; 4():490. PubMed ID: 24400010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lactate in the tumor microenvironment: A rising star for targeted tumor therapy.
    Li Z; Wang Q; Huang X; Yang M; Zhou S; Li Z; Fang Z; Tang Y; Chen Q; Hou H; Li L; Fei F; Wang Q; Wu Y; Gong A
    Front Nutr; 2023; 10():1113739. PubMed ID: 36875841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel mechanism of lung cancer inhibition by methionine enkephalin through remodeling the immune status of the tumor microenvironment.
    Zhang S; Huang H; Handley M; Griffin N; Bai X; Shan F
    Int Immunopharmacol; 2021 Oct; 99():107999. PubMed ID: 34315116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
    Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
    Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.